为非洲提供艾滋病毒/艾滋病治疗和艾滋病毒疫苗
Paul J Weidle1, Timothy D Mastro, Alison D Grant
1Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. pweidle@cdc.gov
Lancet (London, England)
|July 10, 2002
概括
全球支持促进了发展中国家的艾滋病毒/艾滋病治疗和疫苗开发. 研究重点是有效的抗逆转录病毒疗法和新型艾滋病毒疫苗,用于资源贫困的环境.
科学领域:
- 全球健康 全球健康
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 全球艾滋病毒/艾滋病社区的支持增加推动了治疗和疫苗开发的进步,特别是在发展中国家.
- 获得性免疫缺陷综合征 (艾滋病) 患者的护理包括生物医学,营养,心理社会和行为干预.
- 资源贫困的环境需要标准化的抗逆转录病毒药物治疗方案和简化监测算法,以有效管理艾滋病毒.
研究的目的:
- 审查在资源乏的环境中实施艾滋病毒治疗和疫苗战略的前景.
- 强调开发安全有效的艾滋病毒疫苗对于预防和疾病修饰的重要性.
- 讨论非洲需要进行艾滋病毒疫苗疗效试验的必要性.
主要方法:
- 关于艾滋病毒/艾滋病治疗和疫苗研究的当前文献的综述.
- 分析了解艾滋病毒免疫学和疫苗候选人开发的进展.
- 讨论在资源有限的环境中实施的挑战和机会.
主要成果:
- 在了解对艾滋病毒的免疫反应和开发新的候选疫苗方面取得了重大进展,包括针对非洲HIV-1菌株的疫苗.
- 抗逆转录病毒疗法 (ART) 需要标准化方案和高效的监测,以在资源贫乏的环境中获得最佳结果.
- 艾滋病毒疫苗疗效试验在非洲至关重要,以评估新疫苗候选人的临床和公共卫生益处.
结论:
- 在资源乏的环境中,有效的艾滋病毒/艾滋病护理依赖于优化治疗方案和开发新型预防策略的结合.
- 艾滋病毒疫苗研究的进展,特别是与非洲菌株相关的进展,有望补充现有的预防工作.
- 将科学进步转化为有形的公共卫生益处,需要针对不同人群进行有针对性的疗效试验,特别是在非洲.
相关概念视频
Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


